However, brain specimens from diacerein treated group showed a marked surge in percentage area immunostained with GFAP by nearly 4-folds (P < 0.0001), compared with HE group (Fig. 5C and D), F (2, 15) = 108.4, P < 0.0001. The gene discussed is GFAP; the disease is hereditary elliptocytosis.